HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haiyan Fu Selected Research

Therapeutics

5/2024Factors influencing pathological changes in the liver tissue in hepatitis B virus carriers with low-level viremia.
11/2023Nomogram for predicting the prognosis of metastatic colorectal cancer patients treated with anti-PD1 therapy based on serum lipids analysis.
1/2022The fibrogenic niche in kidney fibrosis: components and mechanisms.
5/2020Sequential Wnt Agonist Then Antagonist Treatment Accelerates Tissue Repair and Minimizes Fibrosis.
6/2017Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients.
1/2017Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.
1/2017Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients.
12/2015Recombinant human interleukin-11 (IL-11) is a protective factor in severe sepsis with thrombocytopenia: A case-control study.
11/2012β-Diketone modified trastuzumab: a next-generation of Herceptin for resistant breast cancer cells?
6/2011Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haiyan Fu Research Topics

Disease

16Fibrosis (Cirrhosis)
05/2024 - 11/2016
14Mucopolysaccharidosis III (Sanfilippo Syndrome)
01/2023 - 01/2002
9Acute Kidney Injury (Acute Renal Failure)
05/2024 - 01/2016
9Neoplasms (Cancer)
11/2023 - 05/2006
9Mucopolysaccharidoses
10/2017 - 03/2009
7Chronic Renal Insufficiency
01/2024 - 01/2020
7Sepsis (Septicemia)
03/2023 - 08/2015
7Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2017 - 03/2009
6Reperfusion Injury
01/2023 - 01/2018
5Inflammation (Inflammations)
05/2024 - 11/2014
5Kidney Diseases (Kidney Disease)
01/2023 - 02/2016
5Proteinuria
01/2022 - 10/2016
4Albuminuria
01/2022 - 10/2016
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 10/2016
3Disease Progression
12/2019 - 07/2010
2Infections
05/2024 - 11/2012
2Ureteral Obstruction
01/2024 - 01/2023
2Neuroinflammatory Diseases
03/2023 - 07/2010
2Virus Diseases (Viral Diseases)
01/2023 - 05/2019
2Carcinogenesis
06/2021 - 10/2020
2Liver Diseases (Liver Disease)
06/2021 - 05/2019
2Critical Illness (Critically Ill)
07/2017 - 01/2015
2Neurologic Manifestations (Neurological Manifestations)
07/2010 - 03/2009
2Central Nervous System Diseases (CNS Diseases)
03/2009 - 12/2003
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2024
1Chronic Hepatitis (Chronic Active Hepatitis)
05/2024
1Viremia
05/2024
1Liver Failure
12/2023
1Colorectal Neoplasms (Colorectal Cancer)
11/2023
1Chronic Disease (Chronic Diseases)
04/2023
1Diabetes Mellitus
04/2023
1Cognitive Dysfunction
03/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1COVID-19
01/2023
1Hypoxia (Hypoxemia)
01/2023
1Heart Failure
03/2022
1Wilms Tumor (Wilm's Tumor)
01/2022
1Intrahepatic Cholestasis
01/2022

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2013
7CateninsIBA
01/2024 - 01/2016
7alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA
01/2017 - 01/2002
6Proteins (Proteins, Gene)FDA Link
05/2024 - 04/2013
5Peptides (Polypeptides)IBA
11/2022 - 11/2012
4limoninIBA
12/2023 - 10/2019
4Cisplatin (Platino)FDA LinkGeneric
12/2023 - 01/2019
4CreatinineIBA
01/2021 - 11/2016
4GlycosaminoglycansIBA
10/2017 - 01/2002
3TenascinIBA
01/2020 - 03/2017
3EnzymesIBA
10/2017 - 03/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017 - 07/2010
3Acetylglucosaminidase (NAGase)IBA
01/2017 - 06/2014
2AlbuminsIBA
05/2024 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
05/2024 - 11/2012
2LipidsIBA
11/2023 - 10/2017
2RNA (Ribonucleic Acid)IBA
11/2023 - 10/2020
2Glucose (Dextrose)FDA LinkGeneric
04/2023 - 12/2019
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2023 - 01/2023
2CalponinsIBA
01/2023 - 01/2023
2Estrogen Receptor betaIBA
01/2023 - 01/2023
2ChromatinIBA
01/2023 - 01/2023
2Immunoglobulin G (IgG)IBA
01/2023 - 03/2009
2AntigensIBA
01/2023 - 05/2006
2IntegrinsIBA
01/2023 - 01/2020
2Streptozocin (Streptozotocin)FDA Link
01/2022 - 10/2016
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 11/2019
2MicroRNAs (MicroRNA)IBA
06/2021 - 01/2010
2NitrogenIBA
01/2021 - 01/2019
2Urea (Carbamide)FDA LinkGeneric
01/2021 - 01/2019
2Glycoproteins (Glycoprotein)IBA
01/2020 - 03/2017
2LigandsIBA
01/2019 - 04/2013
2Matrix Metalloproteinase 7 (Matrilysin)IBA
01/2019 - 01/2017
2AntibodiesIBA
12/2017 - 03/2011
2urinastatin (MR 20)IBA
06/2017 - 01/2017
2ThymalfasinIBA
06/2017 - 01/2017
2LipopolysaccharidesIBA
11/2016 - 08/2015
2Indicators and Reagents (Reagents)IBA
12/2015 - 12/2003
2SulfotransferasesIBA
08/2015 - 03/2011
2Complement System Proteins (Complement)IBA
11/2012 - 03/2009
2RNA-Binding Proteins (RNA-Binding Protein)IBA
05/2012 - 01/2010
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2024
1Antiviral Agents (Antivirals)IBA
05/2024
1NADP (NADPH)IBA
11/2023
1Neuroprotective AgentsIBA
03/2023
1CytokinesIBA
03/2023
1Messenger RNA (mRNA)IBA
01/2023
1saracatinibIBA
01/2023
1VitronectinIBA
01/2023
1p38 Mitogen-Activated Protein KinasesIBA
01/2023
1NADPH Oxidase 2IBA
01/2023
1TroponinIBA
03/2022
1Oxygen (Dioxygen)IBA
03/2022
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2022
1podocalyxinIBA
01/2022
1Decellularized Extracellular MatrixIBA
01/2022

Therapy/Procedure

11Therapeutics
05/2024 - 03/2011
4Intravenous Injections
01/2022 - 06/2014
2Length of Stay
01/2015 - 11/2014
2Enteral Nutrition (Feeding, Tube)
01/2015 - 11/2014
1Tissue Scaffolds
01/2023
1Art Therapy
01/2023